Tatiana Dimitriou

Dr. Tatiana Dimitriou

Aristotle University, Thessaloníki, Kentrikí Makedonía, Greece
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2020 in Behavioural Brain Research
Verified
Journal Article
Closed access
Tatiana DimitriouTatiana Dimitriou
Tatiana Dimitriou
EVEleni Verykouki
Eleni Verykouki
JPJohn D. Papatriantafyllou
John D. Papatriantafyllou
AKANASTASIA KONSTA
ANASTASIA KONSTA
DKDimitrios A. Kazis
Dimitrios A. Kazis
Magda TsolakiMagda Tsolaki
Magda Tsolaki

26 May 2022 in Brain Sciences
Verified
Journal Article
Open access
PDF file
Tatiana DimitriouTatiana Dimitriou
Tatiana Dimitriou
JPJohn D. Papatriantafyllou
John D. Papatriantafyllou
AKANASTASIA KONSTA
ANASTASIA KONSTA
DKDimitrios A. Kazis
Dimitrios A. Kazis
LALoukas Athanasiadis
Loukas Athanasiadis
Magda TsolakiMagda Tsolaki
Magda Tsolaki
Introduction: Dementia is a very common disorder that affects people over 65 years old all over the world. Apart from the cognitive decline, Behavioral and Psychological Symptoms of Dementia (BPSD) are a crucial matter in dementia, because they affect up to 90% of the patients during the course of their illness. Irritability has been found to be a common BPSD and one of the most distressing behaviors for the caregivers. The aim of the current study was to explore the efficacy of a combination of non-pharmacological interventions to treat irritability. Methods: Sixty patients with different types and stages of dementia with irritability were participated in a cross-over RCT. Three non-pharmacological interventions were used; (a) Validation Therapy (VT)/Psycho-educational program, (b) Aromatherapy/massage and (c) Music Therapy (MT). The study assessed the three non-pharmacological interventions in order to find the most effective combination of the interventions. This study did not compare pharmacological and non-pharmacological treatments. The interventions lasted for five days. There was no drop-out rate. All patients were assessed at baseline using Mini Mental State of Examination (MMSE), Addenbrooke’s Cognitive Examination Revised (ACE-R), Geriatric Depression Scale (GDS), Functional Rating Scale for symptoms in dementia (FRSSD), and Neuropsychiatric Inventory (NPI) (sub questions for irritability). Only NPI used for the assessment after each intervention. The analyses used categorical variables, Wilcoxon signed-rank test, Chi-square test and z value score. Results: The most effective combination of non-pharmacological interventions was Aromatherapy/massage (p = 0.003)-VT plus Psycho-educational program (p = 0.014) plus MT (p = 0.018). The same combination was the most effective for the caregivers’ burden, too (p = 0.026). Conclusions: The above combination of non-pharmacological interventions can reduce irritability in patients with dementia and caregivers’ burden.

19 January 2022 in Brain Sciences
Verified
Journal Article
Open access
PDF file
Tatiana DimitriouTatiana Dimitriou
Tatiana Dimitriou
JPJohn D. Papatriantafyllou
John D. Papatriantafyllou
AKANASTASIA KONSTA
ANASTASIA KONSTA
DKDimitrios A. Kazis
Dimitrios A. Kazis
LALoukas Athanasiadis
Loukas Athanasiadis
Magda TsolakiMagda Tsolaki
Magda Tsolaki
Background: Aberrant motor behaviour or wandering refers to aimless movement without a specific purpose. Wandering is common in patients with dementia and leads to early institutionalization and caregivers’ burden. Non-pharmacological interventions should be also considered as a first-line solution for the wandering because current pharmacological treatment has serious side-effects. Methods: A cross-over randomised controlled trial (RCT) with 60 participants of all stages and different types of dementia was conducted in Greece. The sample was randomly assigned in 6 different groups of 10 participants each. Every intervention lasted for 5 days, and there were 2 days as a wash-out period. There was no drop-out rate. The measurements used were the Mini Mental State Examination (MMSE), Addenbrooke’s Cognitive Examination Revised (ACE-R), Geriatric Depression Scale (GDS), Functional Rating Scale for Symptoms in Dementia (FRSSD), and Neuropsychiatric Inventory (NPI). The interventions that were evaluated were reminiscence therapy (RT), music therapy (MT), and physical exercise (PE). Results: NPI scores were reduced in the group receiving PE (p = 0.006). When MT (p = 0.018) follows PE, wandering symptoms are reduced further. RT should follow MT in order to reduce wandering more (p = 0.034). The same combination was effective for the caregivers’ burden as well; PE (p = 0.004), MT (p = 0.036), RT (p = 0.039). Conclusions: An effective combination that can reduce wandering symptoms in all stages and types of dementia was found: The best order was PH-MT-RT. The same combination in the same order reduced caregivers’ burden.

1 July 2018
Verified
Journal Article
Closed access
Tatiana DimitriouTatiana Dimitriou
Tatiana Dimitriou
EVEleni Verykouki
Eleni Verykouki
JPJohn Papatriantafyllou
John Papatriantafyllou
AKAnastasia Konsta
Anastasia Konsta
DKDimitrios Kazis
Dimitrios Kazis
Magda TsolakiMagda Tsolaki
Magda Tsolaki

12 December 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Tatiana DimitriouTatiana Dimitriou
Tatiana Dimitriou
TPTheodore Parthimos
Theodore Parthimos
VKVasiliki Kamtsadeli
Vasiliki Kamtsadeli
NTNiki Tsinia
Niki Tsinia
MHMaria Hatzopoulou
Maria Hatzopoulou
JPJohn D. Papatriantafyllou
John D. Papatriantafyllou
Background: Social cognition helps people to understand their own and others’ behavior and to modulate the way of thinking and acting in different social situations. Rapid and accurate diagnoses of neurodegenerative diseases are essential, as social cognition is affected by these diseases. The Revised Self-Monitoring Scale (RSMS) is a scale that detects social–emotional cognition deficits. Aim: The aim of the current study is to examine how socioemotional parameters are affected by neurodegenerative diseases and whether the RSMS can discern these disorders based on the socioemotional parameters in the Greek population. Methods/Design: A total of 331 dementia subjects were included. Mini Mental State Examination (MMSE) and Addenbrooke’s Cognitive Examination (Revised, ACE-R) measurements were used in order to assess the cognitive deficits. The Neuropsychiatric Inventory (NPI) was used for the evaluation of the neuropsychiatric symptoms. The RSMS and its two subscales was used in order to detect the socioemotional deficits. Results: The RSMS and its two subscales (RSMS_EX and RSMS_SP) can effectively detect neurodegenerative diseases. The RSMS can detect bvFTD in Alzheimer’s Disease (AD), AD in a healthy cohort, behavioral variant Frontotemporal Dementia (bvFTD) in a healthy cohort, bvFTD in Parkinson’s Disease (PD) and Frontotemporal Semantic Dementia (FTD/SD) in a healthy cohort. It is a useful tool in order to detect frontotemporal dementias. RSMS correlated negatively with the NPI questionnaire total and the subcategories of apathy, disinhibition and eating disorders. The RSMS results are associated with the ACE-R score (specifically verbal fluency). Conclusions: The RSMS is a helpful tool in order to identify socioemotional deficits in neurodegenerative dementias. It is also a useful scale that can discern bvFTD and svPPA in AD patients. A worse RSMS score correlates with a worse ACE-R and NPI. It seems to be a useful scale that can reliably measure social behavior in non-reversible neurodegenerative disorders, such as AD, FTD (bvFTD, svPPA), PDD and PD. The results also apply to the Greek population.

12 July 2023 in JMIR Research Protocols
Verified
Journal Article
Open access
SMSibylle Mellinghoff
Sibylle Mellinghoff
GGGero von Gersdorff
Gero von Gersdorff
CBCaroline Bruns
Caroline Bruns
KAKerstin Albus
Kerstin Albus
Tatiana DimitriouTatiana Dimitriou
Tatiana Dimitriou
BLBlasius Janusch Liss
Blasius Janusch Liss
Background: Pneumonia is a leading cause of death in patients with end-stage chronic kidney disease treated with dialysis. Current vaccination schedules recommend pneumococcal vaccination. However, this schedule disregards findings of rapid titer decline in adult hemodialysis patients after 12 months. Objective: The primary objective is to compare pneumonia rates between recently vaccinated patients and patients vaccinated more than 2 years ago. As an exploratory objective, antipneumococcal antibody titers in hemodialysis patients will be determined as a function. Factors influencing antibody kinetics will be identified. Methods: Within this prospective multicenter study, we aim to compare 2 strata of vaccinated patients: those recently vaccinated and those vaccinated more than 2 years ago. A total of 792 patients will be enrolled. Twelve partner sites (within the German Centre for Infection Research [DZIF]) with allocated dialysis practices participate in this study. All dialysis patients who are vaccinated against pneumococcal infection in accordance with Robert Koch Institute guidelines prior to enrollment will be eligible. Data on baseline demographics, vaccination history, and underlying disease will be assessed. Pneumococcal antibody titers will be determined at baseline and every 3 months for 2 years. DZIF clinical trial units coordinate titer assessment schedules and actively follow-up on study patients for 2-5 years after enrollment, including validation of end points of hospitalization, pneumonia, and death. Results: The study has enrolled 792 patients and the last follow-up has been completed. Currently, the statistical and laboratory analyses are ongoing. Conclusions: Results will increase physician adherence to current recommendations. Establishing a framework for the efficient evaluation of guideline recommendations through a combination of routine and study data will inform the evidence base for future guidelines. Trial Registration: ClinicalTrials.gov NCT03350425; https://clinicaltrials.gov/ct2/show/NCT03350425 International Registered Report Identifier (IRRID): DERR1-10.2196/45712